Effect of immunomodulating treatment (usage of DMARDs) in rheumatoid arthritis on depression
Introduction: There are similarities in the level of cytokines in Rheumatoid Arthritis (RA) and depression. That is why, during usage of Disease-modifying antirheumatic drugs (DMARDs) which modulate the the level of cytokines may influence both depression and RA The aim of the study: The aim of this...
Main Authors: | Magdalena Kozyra, Patryk Zimnicki, Natalia Śmiech, Justyna Kaczerska, Martyna Nowińska, Joanna Milanowska |
---|---|
Format: | Article |
Language: | English |
Published: |
Kazimierz Wielki University
2020-08-01
|
Series: | Journal of Education, Health and Sport |
Subjects: | |
Online Access: | https://apcz.umk.pl/czasopisma/index.php/JEHS/article/view/30889 |
Similar Items
-
Treatment adherence to disease-modifying antirheumatic drugs in Chinese patients with rheumatoid arthritis
by: Xia Y, et al.
Published: (2016-05-01) -
GLUCOCORTICOIDS AND RHEUMATOID ARTHRITIS
by: Zhdan V. M., et al.
Published: (2020-12-01) -
Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
by: Marta Madej, et al.
Published: (2019-08-01) -
MODERN VIEWS ON PATHOGENETIC THERAPY OF RHEUMATOID ARTHRITIS
by: D. G. Rekalov, et al.
Published: (2013-12-01) -
Persistence rates of abatacept and TNF inhibitors used as first or second biologic DMARDs in the treatment of rheumatoid arthritis: 9 years of experience from the Rhumadata® clinical database and registry
by: Denis Choquette, et al.
Published: (2019-06-01)